Blog

Now that Elon Musk's rocket and satellite company Space Exploration Technologies (NASDAQ: SPCX) trades publicly, Wall Street has started hunting for the next best thing: stocks that can ride its

Space Exploration Technologies (NASDAQ: SPCX) has become one of the market's most closely watched stocks after its rapid entry into the Nasdaq-100 index on July 7. Shares are trading close to $149

Amazon (NASDAQ: AMZN) is reported to have made a shocking decision in recent days. According to CNBC, it is issuing $25 billion in debt to fund its data center build-out. While it doesn't plan to

It's a dream for most people to earn the title of "millionaire." There's a perception that in order to reach the $1 million mark, you need to either win the lottery or be the beneficiary of a major

Jeffrey L. Radke, Co-Founder and CEO of Accelerant Holdings (NYSE:ARX), sold 80,000 Class A Common Shares on July 6, 2026, for approximately $1.1 million, as disclosed in a recent SEC Form 4 filing.

Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between FBT's highly concentrated portfolio and IBB's broader

The choice between the iShares Ethereum Trust ETF (NASDAQ:ETHA) and the Hashdex Nasdaq Crypto Index US ETF (NASDAQ:NCIQ) hinges on whether an investor seeks pure exposure to one digital asset or a

Space Exploration Technologies (NASDAQ: SPCX) joined the Nasdaq-100 index on July 7. If you own the Invesco QQQ ETF (NASDAQ: QQQ) or the Invesco Nasdaq 100 ETF (NASDAQ: QQQM), you now own a piece of

Stuart Naylor, the Chief Scientific Officer, Ophthalmology of MeiraGTx Holdings plc (NASDAQ:MGTX), sold 27,659 shares of ordinary shares on July 7, 2026, according to an SEC Form 4 filing.

MeiraGTx

Greg Abel took over the CEO job at Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB) from Warren Buffett at the start of 2026. He's already proven to be a more proactive manager when it comes to the

Atlas Infrastructure Partners reported a direct purchase of 2,784 shares of H2O America (NASDAQ:HTO) on July 7, 2026, according to an SEC Form 4 filing.

H2O America is a major regulated water

William Guyer, chief development officer, reported a sale of 20,000 shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) on July 7, 2026, according to an SEC Form 4 filing.

Corcept

Patient FuelCell Energy (NASDAQ: FCEL) investors have been rewarded thus far this year, with the power plant fuel cell specialist's stock rising more than 187% in 2026 and over 275% in the past 12

Director Silvestre Vila Moret executed a direct purchase of 402,967 Class B Ordinary Shares of Grupo Financiero Galicia S.A. (NASDAQ:GGAL), according to a recent SEC Form 4 filing.

Transaction value

The iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) offers targeted exposure to long-dated government debt, while the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSEMKT:LQD) provides broad

Many early Nvidia (NASDAQ: NVDA) investors have become millionaires. While new investors definitely wish they had bought shares earlier, the stock is still trending higher. It's up by 25% over the

Insight Holdings Group reported a sale of 426,000 shares of Hinge Health, Inc. (NYSE:HNGE) on July 7, 2026 and July 9, 2026, totaling $38.4 million, according to an SEC Form 4 filing.

Transaction

If you ever find yourself wondering if it's possible to build a balanced portfolio on your own that cuts through the noise and eliminates unnecessary decisions, the answer is yes. As a bonus, you

Artificial intelligence (AI) has a major bottleneck, and it isn't limited to chips, servers, or memory. Estimates suggest that trillions in investment will be needed to build the power

Mark Schoenberg, Chief Medical Officer, sold 10,000 ordinary shares of UroGen Pharma Ltd. (NASDAQ:URGN) on July 9, 2026, for a total value of $400,000, according to an SEC Form 4 filing.

UroGen

While most of the market's attention right now is on tech and artificial intelligence (AI) stocks, it's worth noting that dividend stocks have a pretty good track record. Sure, they haven't

Nagendran Sukumar, president and head of R&D at Taysha Gene Therapies, Inc. (NASDAQ:TSHA), sold 200,000 shares of common stock on July 10, 2026, for proceeds of $1.2 million, according to a recent

Shawn Morris, former CEO and previously a member of the Board of Directors at Privia Health Group (NASDAQ:PRVA), reported the exercise of 135,498 stock options into common shares and immediately

Here's a fun fact: Last year, data centers globally consumed about 448 terawatt-hours (TWh) of electricity, with artificial intelligence (AI) accounting for a fifth of that total. That's more power

Iconiq Strategic Partners VIII Holdings, an entity holding a major stake in Netskope, Inc. (NASDAQ:NTSK), reported a purchase of 610,291 shares of Class A Common Stock on July 8, according to an SEC